Oral Drug Treatment Helps Protect Cancer Patients from Potentially Deadly DVT and Pulmonary Embolism

Typography

• Cancer patients are at high risk of developing blood clots

• Deep vein thrombosis (DVT) and pulmonary embolism (PE) collectively known as venous thromboembolism (VTE), can cause death and disability

• Cancer patients are at high risk of developing blood clots

• Deep vein thrombosis (DVT) and pulmonary embolism (PE) collectively known as venous thromboembolism (VTE), can cause death and disability

• Tablet found to reduce recurrence of VTE Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) - either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots in the deep veins of the leg may travel to the lungs causing a pulmonary embolism. These two conditions are referred to as VTE - a dangerous and potentially deadly medical condition of which there are 10 million cases worldwide.

Read more at University of Warwick

Image: This is Prof Annie Young. (Credit: University of Warwick)